AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
TREATMENT OF ADVANCED HEAD NECK SQUAMOUS-CELL CARCINOMA IN ELDERLY PATIENTS WITH WEEKLY INTRAVENOUS BLEOMYCIN/
Authors: GEBBIA V FALLICA G BORSELLINO N TESTA A VARVARA F MAUCERI G
Citation: V. Gebbia et al., TREATMENT OF ADVANCED HEAD NECK SQUAMOUS-CELL CARCINOMA IN ELDERLY PATIENTS WITH WEEKLY INTRAVENOUS BLEOMYCIN/, Annals of oncology, 9, 1998, pp. 102-102
CHEMOSENSITIZATION OF HUMAN PROSTATE CARCINOMA CELL-LINES TO ANTI-FAS-MEDIATED CYTOTOXICITY AND APOPTOSIS
Authors: USLU R BORSELLINO N FROST P GARBAN H NG CP MIZUTANI Y BELLDEGRUN A BONAVIDA B
Citation: R. Uslu et al., CHEMOSENSITIZATION OF HUMAN PROSTATE CARCINOMA CELL-LINES TO ANTI-FAS-MEDIATED CYTOTOXICITY AND APOPTOSIS, Clinical cancer research, 3(6), 1997, pp. 963-972
CROSS-RESISTANCE OF TUMOR-CELLS TO CHEMOTHERAPY AND IMMUNOTHERAPY - APPROACHES TO REVERSE RESISTANCE AND IMPLICATIONS IN GENE-THERAPY (REVIEW)
Authors: BONAVIDA B SAFRIT J MORIMOTO H MIZUTANI Y USLU R BORSELLINO N FROST P BEREK J BELLDEGRUN A ZIGHELBOIM J NG CP MORI S
Citation: B. Bonavida et al., CROSS-RESISTANCE OF TUMOR-CELLS TO CHEMOTHERAPY AND IMMUNOTHERAPY - APPROACHES TO REVERSE RESISTANCE AND IMPLICATIONS IN GENE-THERAPY (REVIEW), Oncology Reports, 4, 1997, pp. 201-205
BIOLOGY VERSUS PHARMACOLOGY IN DRUG-RESISTANCE (REVIEW)
Authors: DALESSANDRO N FLUGY A BORSELLINO N TRAVALI S
Citation: N. Dalessandro et al., BIOLOGY VERSUS PHARMACOLOGY IN DRUG-RESISTANCE (REVIEW), Oncology Reports, 4, 1997, pp. 207-210
TREATMENT OF RECURRENT AND OR METASTATIC ADENO-CARCINOMA OF THE ENDOMETRIUM WITH CISPLATINUM AND VINOREL-BINE - A PHASE-II STUDY/
Authors: GEBBIA V TESTA A CANNATA G TIRRITO ML BORSELLINO N VALERIO MR VARVARA F GEBBIA N
Citation: V. Gebbia et al., TREATMENT OF RECURRENT AND OR METASTATIC ADENO-CARCINOMA OF THE ENDOMETRIUM WITH CISPLATINUM AND VINOREL-BINE - A PHASE-II STUDY/, European journal of cancer, 33, 1997, pp. 934-934
ELFE (ETOPOSIDE, FOLINIC ACID, 5-FLUOROURACIL, AND EPIRUBICIN) REGIMEN IN THE TREATMENT OF ADVANCED PANCREATIC-CANCER (APC)
Authors: MAIELLO E GEBBIA V GIULIANI F TESTA A BORSELLINO N GALETTA D GEBBIA N COLUCCI G
Citation: E. Maiello et al., ELFE (ETOPOSIDE, FOLINIC ACID, 5-FLUOROURACIL, AND EPIRUBICIN) REGIMEN IN THE TREATMENT OF ADVANCED PANCREATIC-CANCER (APC), European journal of cancer, 33, 1997, pp. 1270-1270
CISPLATIN AND EPIRUBICIN PLUS ORAL LONIDAMINE AS FIRST-LINE TREATMENTFOR METASTATIC BREAST-CANCER - A PHASE-II STUDY OF THE SOUTHERN ITALYONCOLOGY GROUP (GOIM)
Authors: GEBBIA V BORSELLINO N TESTA A LATTERI MA MILIA V VALDESI M GIOTTA F GEBBIA N COLUCCI G
Citation: V. Gebbia et al., CISPLATIN AND EPIRUBICIN PLUS ORAL LONIDAMINE AS FIRST-LINE TREATMENTFOR METASTATIC BREAST-CANCER - A PHASE-II STUDY OF THE SOUTHERN ITALYONCOLOGY GROUP (GOIM), Anti-cancer drugs, 8(10), 1997, pp. 943-948
DEVELOPMENT AND PARTIAL CHARACTERIZATION OF A HUMAN T-LYMPHOBLASTIC LEUKEMIC (CCRF-CEM) CELL-LINE RESISTANT TO ETOPOSIDE - ANALYSIS OF POSSIBLE CIRCUMVENTING APPROACHES
Authors: FLANDINA C FLUGY A BORSELLINO N DALESSANDRO N
Citation: C. Flandina et al., DEVELOPMENT AND PARTIAL CHARACTERIZATION OF A HUMAN T-LYMPHOBLASTIC LEUKEMIC (CCRF-CEM) CELL-LINE RESISTANT TO ETOPOSIDE - ANALYSIS OF POSSIBLE CIRCUMVENTING APPROACHES, Journal of chemotherapy, 8(6), 1996, pp. 465-471
USEFULNESS OF ORAL MEDROXYPROGESTERONE ACETATE IN THE MANAGEMENT OF CANCER-RELATED CACHEXIA-ANOREXIA SYNDROME
Authors: TESTA A GEBBIA V BORSELLINO N VALENZA R CANNATA G TIRRITO M VERDERAME F ARMATA MG VALERIO MR GEBBIA N
Citation: A. Testa et al., USEFULNESS OF ORAL MEDROXYPROGESTERONE ACETATE IN THE MANAGEMENT OF CANCER-RELATED CACHEXIA-ANOREXIA SYNDROME, Oncology Reports, 3(3), 1996, pp. 493-496
TNF-INDUCED APOPTOSIS IN MULTIDRUG-RESISTANT FRIEND-ERYTHROLEUKEMIA IS NOT INFLUENCED BY THE P-GLYCOPROTEIN AND GLUTATHIONE STATUS OF THE CELL-LINE (VOL 7, PG 559, 1995)
Authors: FLUGY A BORSELLINO N DALESSANDRO N
Citation: A. Flugy et al., TNF-INDUCED APOPTOSIS IN MULTIDRUG-RESISTANT FRIEND-ERYTHROLEUKEMIA IS NOT INFLUENCED BY THE P-GLYCOPROTEIN AND GLUTATHIONE STATUS OF THE CELL-LINE (VOL 7, PG 559, 1995), Oncology research, 8(3), 1996, pp. 145-145
IN-VIVO EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA OR FLAVONE ACETIC-ACIDIN COMBINATION WITH DOXORUBICIN ON MULTIDRUG-RESISTANT B16 MELANOMA
Authors: DALESSANDRO N BORSELLINO N
Citation: N. Dalessandro et N. Borsellino, IN-VIVO EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA OR FLAVONE ACETIC-ACIDIN COMBINATION WITH DOXORUBICIN ON MULTIDRUG-RESISTANT B16 MELANOMA, Anti-cancer drugs, 7(3), 1996, pp. 281-287
TNF-INDUCED APOPTOSIS IN MULTIDRUG-RESISTANT FRIEND-ERYTHROLEUKEMIA IS NOT INFLUENCED BY THE P-GLYCOPROTEIN AND GLUTATHIONE STATUS OF THE CELL-LINE
Authors: FLUGY A BORSELLINO N DALESSANDRO N
Citation: A. Flugy et al., TNF-INDUCED APOPTOSIS IN MULTIDRUG-RESISTANT FRIEND-ERYTHROLEUKEMIA IS NOT INFLUENCED BY THE P-GLYCOPROTEIN AND GLUTATHIONE STATUS OF THE CELL-LINE, Oncology research, 7(10-11), 1995, pp. 559-564
IL-6 IS A RESISTANT FACTOR IN RESISTANT HUNAN PROSTATE-CANCER CELL-LINES AND ITS INHIBITION SENSITIZES THE CELLS TO CYTOTOXICITY BY CDDP
Authors: BORSELLINO N BELLDEGRUN A BONAVIDA B
Citation: N. Borsellino et al., IL-6 IS A RESISTANT FACTOR IN RESISTANT HUNAN PROSTATE-CANCER CELL-LINES AND ITS INHIBITION SENSITIZES THE CELLS TO CYTOTOXICITY BY CDDP, The FASEB journal, 9(3), 1995, pp. 223-223
ENDOGENOUS INTERLEUKIN-6 IS A RESISTANCE FACTOR FOR CIS-DIAMMINEDICHLOROPLATINUM AND ETOPOSIDE-MEDIATED CYTOTOXICITY OF HUMAN PROSTATE CARCINOMA CELL-LINES
Authors: BORSELLINO N BELLDEGRUN A BONAVIDA B
Citation: N. Borsellino et al., ENDOGENOUS INTERLEUKIN-6 IS A RESISTANCE FACTOR FOR CIS-DIAMMINEDICHLOROPLATINUM AND ETOPOSIDE-MEDIATED CYTOTOXICITY OF HUMAN PROSTATE CARCINOMA CELL-LINES, Cancer research, 55(20), 1995, pp. 4633-4639
EFFECT OF BUTHIONINE SULFOXIMINE ON THE SENSITIVITY TO DOXORUBICIN OFPARENT AND MDR TUMOR-CELL LINES
Authors: CRESCIMANNO M BORSELLINO N LEONARDI V FLANDINA C FLUGY A RAUSA L DALESSANDRO N
Citation: M. Crescimanno et al., EFFECT OF BUTHIONINE SULFOXIMINE ON THE SENSITIVITY TO DOXORUBICIN OFPARENT AND MDR TUMOR-CELL LINES, Journal of chemotherapy, 6(5), 1994, pp. 343-348
EFFECT OF BUTHIONINE SULFOXIMINE ON THE SENSITIVITY TO DOXORUBICIN OFPARENT AND MDR TUMOR-CELL LINES
Authors: CRESCIMANNO M BORSELLINO N LEONARDI V FLANDINA C FLUGY A RAUSA L DALESSANDRO N
Citation: M. Crescimanno et al., EFFECT OF BUTHIONINE SULFOXIMINE ON THE SENSITIVITY TO DOXORUBICIN OFPARENT AND MDR TUMOR-CELL LINES, Journal of chemotherapy, 6(5), 1994, pp. 343-348
EFFECTS OF 8-CHLORO-CYCLIC ADENOSINE-MONOPHOSPHATE ON THE GROWTH AND SENSITIVITY TO DOXORUBICIN OF MULTIDRUG-RESISTANT TUMOR-CELL LINES
Authors: BORSELLINO N CRESCIMANNO M LEONARDI V DALESSANDRO N
Citation: N. Borsellino et al., EFFECTS OF 8-CHLORO-CYCLIC ADENOSINE-MONOPHOSPHATE ON THE GROWTH AND SENSITIVITY TO DOXORUBICIN OF MULTIDRUG-RESISTANT TUMOR-CELL LINES, Pharmacological research, 30(1), 1994, pp. 81-90
COMBINATIVE GROWTH-INHIBITORY EFFECTS OF INTERFERON-ALPHA AND DOXORUBICIN ON MULTIDRUG-RESISTANT TUMOR-CELL LINES
Authors: LEONARDI V BORSELLINO N CRESCIMANNO M FLANDINA C FLUGY A DALESSANDRO N
Citation: V. Leonardi et al., COMBINATIVE GROWTH-INHIBITORY EFFECTS OF INTERFERON-ALPHA AND DOXORUBICIN ON MULTIDRUG-RESISTANT TUMOR-CELL LINES, Oncology Reports, 1(1), 1994, pp. 161-164
METHOTREXATE, VINBLASTINE, EPIDOXORUBICIN, AND BLEOMYCIN AS 2ND-LINE CHEMOTHERAPY FOR RECURRENT AND OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK/
Authors: GEBBIA V VALENZA R TESTA A BORSELLINO N CANNATA G RESTIVO S SPECIALE R INGRIA F SPADAFORA G GEBBIA N
Citation: V. Gebbia et al., METHOTREXATE, VINBLASTINE, EPIDOXORUBICIN, AND BLEOMYCIN AS 2ND-LINE CHEMOTHERAPY FOR RECURRENT AND OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK/, ORL, 56(5), 1994, pp. 279-282
COMBINED ACTIVITY OF INTERLEUKIN-1ALPHA OR TNF-ALPHA AND DOXORUBICIN ON MULTIDRUG-RESISTANT CELL-LINES - EVIDENCE THAT TNF AND DXR HAVE SYNERGISTIC ANTITUMOR AND DIFFERENTIATION-INDUCING EFFECTS
Authors: BORSELLINO N CRESCIMANNO M FLANDINA C FLUGY A DALESSANDRO N
Citation: N. Borsellino et al., COMBINED ACTIVITY OF INTERLEUKIN-1ALPHA OR TNF-ALPHA AND DOXORUBICIN ON MULTIDRUG-RESISTANT CELL-LINES - EVIDENCE THAT TNF AND DXR HAVE SYNERGISTIC ANTITUMOR AND DIFFERENTIATION-INDUCING EFFECTS, Anticancer research, 14(6B), 1994, pp. 2643-2648
A PROSPECTIVE RANDOMIZED TRIAL OF THYMOPENTIN VERSUS GRANULOCYTE - COLONY-STIMULATING FACTOR WITH OR WITHOUT THYMOPENTIN IN THE PREVENTION OF FEBRILE EPISODES IN CANCER-PATIENTS UNDERGOING HIGHLY CYTOTOXIC CHEMOTHERAPY
Authors: GEBBIA V TESTA A BORSELLINO N GEBBIA N VALENZA R CANNATA G
Citation: V. Gebbia et al., A PROSPECTIVE RANDOMIZED TRIAL OF THYMOPENTIN VERSUS GRANULOCYTE - COLONY-STIMULATING FACTOR WITH OR WITHOUT THYMOPENTIN IN THE PREVENTION OF FEBRILE EPISODES IN CANCER-PATIENTS UNDERGOING HIGHLY CYTOTOXIC CHEMOTHERAPY, Anticancer research, 14(2B), 1994, pp. 731-734
ETOPOSIDE, DOXORUBICIN (ADRIAMYCIN) AND CISPLATIN REGIMEN IN ADVANCEDGASTRIC ADENOCARCINOMA - EXPERIENCE WITH A LOWER DOSE SCHEDULE
Authors: GEBBIA V VALENZA R TESTA A SCIUME C LONGO A CIPOLLA C BORSELLINO N LEO P LATTERI M FLORENA M GEBBIA N
Citation: V. Gebbia et al., ETOPOSIDE, DOXORUBICIN (ADRIAMYCIN) AND CISPLATIN REGIMEN IN ADVANCEDGASTRIC ADENOCARCINOMA - EXPERIENCE WITH A LOWER DOSE SCHEDULE, Journal of cancer research and clinical oncology, 120(9), 1994, pp. 550-552
A PROSPECTIVE EVALUATION OF THE ACTIVITY OF HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR ON THE PREVENTION OF CHEMOTHERAPY-RELATED NEUTROPENIA IN PATIENTS WITH ADVANCED-CARCINOMA
Authors: GEBBIA V TESTA A VALENZA R BORSELLINO N CIPOLLA C CANNATA G CURTO G LATTERI M FLORENA M GEBBIA N
Citation: V. Gebbia et al., A PROSPECTIVE EVALUATION OF THE ACTIVITY OF HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR ON THE PREVENTION OF CHEMOTHERAPY-RELATED NEUTROPENIA IN PATIENTS WITH ADVANCED-CARCINOMA, Journal of chemotherapy, 5(3), 1993, pp. 186-190
TREATMENT OF RECURRENT AND OR METASTATIC TRANSITIONAL-CELL URINARY-BLADDER CARCINOMA WITH METHOTREXATE, CISPLATIN, AND HIGH-DOSE EPIDOXORUBICIN WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR
Authors: TESTA A GEBBIA V CARRECA I BORSELLINO N VALENZA R CANNATA G GEBBIA N
Citation: A. Testa et al., TREATMENT OF RECURRENT AND OR METASTATIC TRANSITIONAL-CELL URINARY-BLADDER CARCINOMA WITH METHOTREXATE, CISPLATIN, AND HIGH-DOSE EPIDOXORUBICIN WITH OR WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR, Cancer research, therapy & control, 3(4), 1993, pp. 303-307
SUBCUTANEOUS OCTREOTIDE VERSUS ORAL LOPERAMIDE IN THE TREATMENT OF DIARRHEA FOLLOWING CHEMOTHERAPY
Authors: GEBBIA V CARRECA I TESTA A VALENZA R CURTO G CANNATA G BORSELLINO N LATTERI MA CIPOLLA C FLORENA M GEBBIA N
Citation: V. Gebbia et al., SUBCUTANEOUS OCTREOTIDE VERSUS ORAL LOPERAMIDE IN THE TREATMENT OF DIARRHEA FOLLOWING CHEMOTHERAPY, Anti-cancer drugs, 4(4), 1993, pp. 443-445
Risultati: 1-25 | 26-26